News
BLRX
3.020
+1.34%
0.040
Weekly Report: what happened at BLRX last week (0202-0206)?
Weekly Report · 14h ago
Weekly Report: what happened at BLRX last week (0126-0130)?
Weekly Report · 02/02 09:52
Weekly Report: what happened at BLRX last week (0119-0123)?
Weekly Report · 01/26 09:52
Weekly Report: what happened at BLRX last week (0112-0116)?
Weekly Report · 01/19 09:56
Weekly Report: what happened at BLRX last week (0105-0109)?
Weekly Report · 01/12 09:55
Weekly Report: what happened at BLRX last week (1229-0102)?
Weekly Report · 01/05 09:52
Weekly Report: what happened at BLRX last week (1222-1226)?
Weekly Report · 12/29/2025 09:51
Weekly Report: what happened at BLRX last week (1215-1219)?
Weekly Report · 12/22/2025 09:51
Weekly Report: what happened at BLRX last week (1208-1212)?
Weekly Report · 12/15/2025 09:56
Weekly Report: what happened at BLRX last week (1201-1205)?
Weekly Report · 12/08/2025 09:55
Weekly Report: what happened at BLRX last week (1124-1128)?
Weekly Report · 12/01/2025 09:52
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
TipRanks · 11/26/2025 00:06
BioLineRx Reports Q3 2025 Results and Strategic Expansion
TipRanks · 11/25/2025 03:53
BioLine Rx Q3 EPADS $(0.22) Beats $(1.20) Estimate, Sales $427.000K Miss $990.000K Estimate
Benzinga · 11/24/2025 22:36
Analysts Are Bullish on Top Healthcare Stocks: Bioline RX Ltd Sponsored ADR (BLRX), Ocular Therapeutix (OCUL)
TipRanks · 11/24/2025 20:00
BioLineRx Announces Q3 2025 Financial Results and New Joint Venture
TipRanks · 11/24/2025 15:49
BioLineRx reports $0.4 million in third quarter 2025 revenues
Reuters · 11/24/2025 15:20
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
TipRanks · 11/24/2025 14:01
Israeli biopharma BioLineRx's Q3 loss narrows as costs drop
Reuters · 11/24/2025 12:17
Options Volatility and Implied Earnings Moves Today, November 24, 2025
TipRanks · 11/24/2025 12:05
More
Webull provides a variety of real-time BLRX stock news. You can receive the latest news about Biolinerx through multiple platforms. This information may help you make smarter investment decisions.
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.